Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 739

1.

Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.

Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K, et al.

Pediatrics. 1995 Sep;96(3 Pt 1):451-8.

PMID:
7651777
2.

The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.

Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, Miotti PG.

Int J Epidemiol. 1995 Oct;24(5):1022-9.

PMID:
8557435
3.

Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.

Newell ML, Borja MC, Peckham C; European Collaborative Study.

Pediatrics. 2003 Jan;111(1):e52-60.

PMID:
12509595
4.

Perinatal human immunodeficiency virus-1 transmission and intrauterine growth: a cohort study in Butare, Rwanda.

Weng S, Bulterys M, Chao A, Stidley CA, Dushimimana A, Mbarutso E, Saah A.

Pediatrics. 1998 Aug;102(2):e24.

PMID:
9685470
5.

Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.

Bamji M, Thea DM, Weedon J, Krasinski K, Matheson PB, Thomas P, Lambert G, Abrams EJ, Steketee R, Heagarty M.

Pediatr Infect Dis J. 1996 Oct;15(10):891-8.

PMID:
8895922
6.

Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.

Ioannidis JP, Taha TE, Kumwenda N, Broadhead R, Mtimavalye L, Miotti P, Yellin F, Contopoulos-Ioannidis DG, Biggar RJ.

Int J Epidemiol. 1999 Aug;28(4):769-75.

7.

Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.

Moye J Jr, Rich KC, Kalish LA, Sheon AR, Diaz C, Cooper ER, Pitt J, Handelsman E.

J Pediatr. 1996 Jan;128(1):58-69.

PMID:
8551422
8.

Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group.

Spira R, Lepage P, Msellati P, Van De Perre P, Leroy V, Simonon A, Karita E, Dabis F.

Pediatrics. 1999 Nov;104(5):e56.

PMID:
10545582
10.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

11.

Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Chotpitayasunondh T, Vanprapar N, Simonds RJ, Chokephaibulkit K, Waranawat N, Mock P, Stat MA, Chuachoowong R, Young N, Mastro TD, Shaffer N.

Pediatrics. 2001 Jan;107(1):E5.

PMID:
11134469
12.

Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.

Nelson AM, Firpo A, Kamenga M, Davachi F, Angritt P, Mullick FG.

Prog AIDS Pathol. 1992;3(1):1-33. Review.

PMID:
1606299
13.

Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group.

Kuhn L, Abrams EJ, Matheson PB, Thomas PA, Lambert G, Bamji M, Greenberg B, Steketee RW, Thea DM.

AIDS. 1997 Mar 15;11(4):429-35.

PMID:
9084789
14.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
15.

Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.

Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H.

Pediatrics. 2000 Jan;105(1):e8.

PMID:
10617745
16.

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG.

AIDS. 1995 Jul;9(7):721-6.

PMID:
7546417
17.

A prospective study of mother-to-infant HIV transmission in tribal women from India.

Kumar RM, Uduman SA, Khurranna AK.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 1;9(3):238-42.

PMID:
7788422
18.

Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.

de Souza RS, Gómez-Marín O, Scott GB, Guasti S, O'Sullivan MJ, Oliveira RH, Mitchell CD.

J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):154-61.

PMID:
10935691
19.

Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.

Lambert JS, Watts DH, Mofenson L, Stiehm ER, Harris DR, Bethel J, Whitehouse J, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H, van Dyke R, Maupin R, Silio M, Fowler MG.

AIDS. 2000 Jul 7;14(10):1389-99.

PMID:
10930154
20.

Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type-1 infection.

Lee MJ, Hallmark RJ, Frenkel LM, Del Priore G.

Int J Gynaecol Obstet. 1998 Dec;63(3):247-52.

PMID:
9989893
Items per page

Supplemental Content

Write to the Help Desk